Featured ArticlesResourcesControlled Drug Classifications: Schedule I, II, III, IV, VSuzanne B. Robotti
MedShadow ArticlesMission Critical Update: Medication Safety Updates from the FDA DelayedEmma Yasinski
MedShadow ArticlesFDA SIDE EFFECTS UPDATE: Remicade and the Onset of New Autoimmune Diseases, Plus MoreKatie Rowley
MedShadow ArticlesMedication Safety For Older Adults: Strategies To Reduce Risk And Improve CareGoldina Erowele, PharmD
MedShadow ArticlesThe PPI Debate: Could Common Heartburn Drugs Be Harming Your Brain?Carrie Arnold, MA, MPH
Drug Interactions/Side EffectsFDA SIDE EFFECTS UPDATE: Baqsimi and Serious Hypersensitivity Reactions, Plus MoreKatie Rowley
FDAMakary’s “Blind Spots” Offers Big Ideas — But Can He Deliver as FDA Commissioner?Suzanne B. Robotti
MedShadow ArticlesFDA SIDE EFFECTS UPDATE: Gadolinium Contrast Agents (GBCAs) and Lung ProblemsKatie Rowley
MedShadow ArticlesFrom Ashwagandha to St. John’s Wort: The Risks Behind 5 Trending SupplementsJessie Sebor
MedShadow ArticlesThe Unsettling Truth About Ciprofloxacin: A Wonder Drug’s Darker SideKristel Tjandra, Madeline Reinsel and Gillian Dohrn
MedShadow ArticlesOpinion: RFK’s “Radical Transparency” Looks More Like A Closed DoorSuzanne B. Robotti
